This inventor holds 1 USPTO granted patent. Top assignee: Shenyang Eye Industry Technology Institute Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Ling Feng: Innovator in Monoclonal Antibody Development
Introduction
Ling Feng is a notable inventor based in Liaoning, China. He has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. His work is recognized for its potential applications in medical science.
Latest Patents
Ling Feng holds a patent for an "ANTI-PERIOSTIN HUMANIZED MONOCLONAL ANTIBODY, AND PREPARATION METHOD THEREFOR AND USE THEREOF." This innovative patent highlights his expertise in creating targeted therapies that could improve treatment options for various diseases.
Career Highlights
Ling Feng is associated with the Shenyang Eye Industry Technology Institute Ltd. His role at this institute allows him to engage in cutting-edge research and development in the field of eye care and related technologies. His dedication to advancing medical science is evident through his innovative work.
Collaborations
Ling Feng collaborates with talented individuals such as Xuejiao Li and Wei He. These partnerships enhance the research environment and foster innovation within their projects.
Conclusion
Ling Feng's contributions to monoclonal antibody development exemplify the impact of innovative research in biotechnology. His work not only advances scientific knowledge but also holds promise for future medical applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile